Kawasaki T. Acute febrile mucocutaneous syndrome with lymphiod involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178–222.
Kato H, Ichinose E, Yoshioka F et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49:1758–66.
Gitiaux C, Kossorotoff M, Bergounioux J et al. Cerebralvasculitis in severe Kawasaki disease: early detection by magneticresonance imaging and good outcome after intensivetreatment. Dev Med Child Neurol 2012;54:1160–3.
Gerding R. Kawasaki disease: a review. J Pediatr Health Care 2011;25:379–87.
Liu R, He B, Gao F et al. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease. Transl Res 2012;160:131–6.
Si F, Wu Y, Gao F, Feng S et al. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease. Clin Exp Med 2017;17:451–7.
Seldin MM, Peterson JM, Byerly MS et al. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 2012;287:11968–80.
Ahima RS, Qi Y, Singhal NS et al. Brain adipocytokine action and metabolic regulation. Diabetes 2006;55:145–54.
Scherer PE, Williams S, Fogliano M et al. A novelserum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746–9.
Wang H, Wang R, Du D et al. Serum levels of C1q/TNF-related protein-1 (CTRP1) are closely associated with coronary artery disease. BMC Cardiovasc Disord 2016;16:92.
Schäffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 2012;23:194–204.
Wong GW, Krawczyk SA, Kitidis-Mitrokostas C et al. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 2008;416:161–77.
Kim KY, Kim HY, Kim JH et al. Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 2006;580:3953–60.
Innamorati G, Whang MI, Molteni R et al. GIP, a G-protein-coupled receptor interacting protein. Regul Pept 2002;109:173–9.
Yuasa D, Ohash K, Shibata R et al. C1q-TNF-related protein functions to protect against acute ischemic injury in the heart. FASEB J 2016;30:1065–75.
Tang JN, Shen BL, Lin CL et al. Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris. Am J Med Sci 2015;349:130–6.
Lasser G, Guchhait P, Ellsworth JL et al. C1qTNF-related protein-1 (CTRP-1): a vascular wallprotein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood 2006;107:423–30.
Japanese Circulation Society Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS2013). Circ J 2014;78:2521–62.
Ayusuwa M, Sonobe T, Uemura S et al. Revision of diagnostic guidlines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232–4.
Pan X, Lu F, Wu F et al. Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS ONE 2014;9:e94478.
Chalupova L, Zakovska A, Adamcova K. Development of a novel enzyme-linked immunosorbent aassay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem 2013;46:73–8.
Lu L, Zhang RY, Wang XQ et al. C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. Eur Heart J 2016;37:23.
Neuburger JW, Takahaski M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708–33.
Komatsu H, Fujisawa T. Kawasaki disease and infection. Nihon Rinsho 2008;66:278–82.
Hiromichi H, Tsuyoshi S, Kunihiro O. Comprehensive pathogen detectin associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next-generation sequencing. JMM Case Rep 2016;3:e005019.
Eleftheriou D, Levin M, Shingadia D et al. Management of Kawasaki disease. Arch Dis Child 2014;99:74–83.
Donato R, A Laura, F Michele et al. Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int J Mol Sci 2016;17:278.